Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tamoxifen vs Exemestane with GnRH Analogue in Male Breast Cancer
NCT01638247Phase 3Completed
- Sponsor
- GBG Forschungs
- Start
- Aug 2012
- Primary completion
- May 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of exemestane in breast cancer, sponsored by GBG Forschungs. Started Aug 2012; status: completed.
02
Drugs
exemestane
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT01638247.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01638247.